Literature DB >> 25440867

Timely pain management in the emergency department.

Patricia A Patrick1, Barry M Rosenthal2, Carina A Iezzi3, Donald A Brand1.   

Abstract

BACKGROUND: Delivering timely pain relief remains a challenge for most emergency departments.
OBJECTIVE: To evaluate the effectiveness of a policy aimed at delivering analgesics within 30 min to patients presenting to an emergency department with severe pain.
METHODS: Subjects were aged ≥19 years, had a principal diagnosis of renal colic, hip fracture, or sickle cell disease, reported a pain score ≥8 on a scale of 0 to 10 at triage, and continued to report a score in this range until receiving analgesia. The study compared proportions of patients receiving analgesics within the 30-min target, median time to analgesic administration, and median time to relief of severe pain (decline in pain level to score <8) during 6 months before vs. 6 months after implementation of the new pain management policy.
RESULTS: Paradoxically, the median total waiting time to analgesic administration increased from 64 min (n = 75) to 80 min (n = 70) after policy implementation (p = 0.01), and the proportion of patients receiving analgesics within 30 min declined from 17% (13/75) to 7% (5/70) (p = 0.08). Median time to relief of severe pain did not differ significantly between periods (130.5 vs. 153 min; p = 0.31).
CONCLUSIONS: After implementation of the new pain management policy, the proportion of patients with severe pain receiving analgesics within 30 min actually declined. Although a 30-min target may be unrealistic, it seems reasonable to conclude that something is wrong when patients with notoriously painful conditions must typically wait 1-2 h to obtain relief. Given the millions of individuals who receive care in emergency departments nationwide each year, the suffering caused by delays occurs on a large scale, so creative approaches are clearly needed to overcome the obstacles.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  analgesics; emergency medicine; pain management

Mesh:

Substances:

Year:  2014        PMID: 25440867     DOI: 10.1016/j.jemermed.2014.09.009

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  6 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

2.  Intravenous morphine titration vs. oral hydrocodone/acetaminophen for adults with lower extremity displaced fracture in an emergency department setting: A randomized controlled trial.

Authors:  Zhengqi Pan; Yongjian Qi; Yinxian Wen; Liaobin Chen
Journal:  Exp Ther Med       Date:  2018-08-14       Impact factor: 2.447

3.  Prevalence and management of pain in dogs in the emergency service of a veterinary teaching hospital.

Authors:  Frédérik Rousseau-Blass; Elizabeth O'Toole; Josée Marcoux; Daniel S J Pang
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

Review 4.  The impact of the advanced practice nursing role on quality of care, clinical outcomes, patient satisfaction, and cost in the emergency and critical care settings: a systematic review.

Authors:  Brigitte Fong Yeong Woo; Jasmine Xin Yu Lee; Wilson Wai San Tam
Journal:  Hum Resour Health       Date:  2017-09-11

5.  Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.

Authors:  Sunghee Kim; Ron Brathwaite; Ook Kim
Journal:  Qual Manag Health Care       Date:  2017 Apr/Jun       Impact factor: 0.926

6.  Studying Protocol-Based Pain Management in the Emergency Department.

Authors:  Akkamahadevi Patil; Madhu Srinivasarangan; Prithvishree Ravindra; Harshit Mundada
Journal:  J Emerg Trauma Shock       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.